---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-030387"
form_type: "8-K"
ticker: "OPK"
cik: "0000944809"
company_name: "OPKO HEALTH, INC."
filed_at: "2023-11-06T23:59:59+00:00"
generated_at: "2026-06-08T21:47:49.055538+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# OPKO Q3 net loss $84.5M; revenues flat; BARDA awards $59M contract for ModeX

## Summary
- Net loss $84.5M ($0.11/sh) vs $86.1M; operating loss improved to $64.4M from $87.8M YoY.
- Diagnostics revenue $131.7M (-8% YoY); operating loss improved 41% to $29.1M on cost cuts.
- Pharmaceuticals revenue $40.7M (+26% YoY) driven by international sales; RAYALDEE up to $7.3M.
- ModeX awarded $59M BARDA contract for multispecific antibodies; up to $109M in milestones.
- NGENLA approved in 48 markets; U.S. gross profit sharing began August 2023; cash $138.6M.

## SEC filing metadata
- accession: 0001437749-23-030387
- form_type: 8-K
- ticker: OPK
- cik: 0000944809
- company_name: OPKO HEALTH, INC.
- filed_at: 2023-11-06T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/944809/000143774923030387/0001437749-23-030387-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/944809/000143774923030387/opk20231024_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-030387
- JSON: https://secwatch.observer/filing/0001437749-23-030387.json
- Plain text: https://secwatch.observer/filing/0001437749-23-030387.txt

## Key facts
- Earnings Releases
  OPKO HEALTH, INC. reported the quarter ended September 30, 2023 results: revenue $178.6 million.
  - Period: the quarter ended September 30, 2023
  - Revenue: $178.6 million
  - Result: reported results
  source text: Consolidated total revenues for the third quarter of 2023 were $178.6 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/944809/000143774923030387/0001437749-23-030387-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.